Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

Trial Phase 4 Completed Jan. 29, 2017

A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)

Trial Phase 1 Completed Jan. 29, 2017

Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes

Trial N/A Completed Jan. 26, 2017

Behavioural Addiction and Genetics in Parkinson's Disease

Trial N/A Completed Jan. 24, 2017

Freezing of Gait in Parkinson's Disease

Trial N/A Completed Jan. 23, 2017

Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease

Trial Phase 4 Terminated Jan. 23, 2017

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Trial Phase 2 Completed Jan. 22, 2017

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Trial Phase 3 Completed Jan. 17, 2017

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

Trial Phase 3 Completed Jan. 17, 2017

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation

Trial N/A Completed Jan. 11, 2017

Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

Trial N/A Completed Jan. 5, 2017

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

Trial Phase 1 Completed Jan. 5, 2017

Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.

Trial Phase 1 Completed Jan. 5, 2017

Lubiprostone as a Treatment for Constipation in Parkinson's Disease

Trial N/A Terminated Dec. 29, 2016

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Trial Phase 1 Completed Dec. 15, 2016

ALTROPANE® SPECT Imaging in Patients With Parkinson Disease

Trial Phase 2 Completed Dec. 15, 2016

Goal-oriented Intervention in Parkinson's Disease

Trial N/A Completed Dec. 13, 2016

Understand FoG in PD: Behavioral Physiology and Clinical Application

Trial N/A Unknown Dec. 7, 2016

Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm

Trial N/A Completed Dec. 4, 2016

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Trial Phase 1 Completed Dec. 4, 2016